GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BioMerieux SA (LTS:0RUG) » Definitions » Credit Losses Provision

BioMerieux (LTS:0RUG) Credit Losses Provision


View and export this data going back to 2007. Start your Free Trial

What is BioMerieux Credit Losses Provision?

Credit Losses Provision only applies to banks.


BioMerieux (LTS:0RUG) Business Description

Address
Marcy l’Etoile, Lyon, FRA, 69280
BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (38% of 2021 sales), microbiology (31%), immunoassays (14%), and industrial applications (about 17%). The Americas account for the largest portion of the firm's revenue (49%), followed by Europe, the Middle East, and Africa (33%), and Asia-Pacific (18%). BioMerieux is headquartered in Marcy-l'Etoile, France.